Zusammenfassung
Während der Schwangerschaft können Windpocken mit schweren Folgen für die Schwangere selbst sowie den Fetus bzw. das Neugeborene verbunden sein. Im Mittelpunkt des vorliegenden Kapitels stehen Empfehlungen für die Labordiagnostik von Varicella-Zoster-Virusinfektionen vor, während sowie nach der Schwangerschaft und/oder beim Neugeborenen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V et al (2013) Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J 32:e305–13
Cohen A, Moschopoulos P, Stiehm RE, Koren G (2011) Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. CMAJ 183:204–208
Enders G, Miller E (2000) Varicella and herpes zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA Ed, Varicella-zoster virus. Virology and clinical management. Cambridge, University Press 317–347
Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343:1548–1551
Gemeinsamer Bundesausschuss zur Empfängnisregelung und zum Schwangerschaftsabbruch (2011) Richtlinie des Gemeinsamen Bundesausschusses zur Empfängnisregelung und zum Schwangerschaftsabbruch. Fassung vom 15.09.2011
Hanngren K, Grandien M, Granström G (1985) Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 17:343–347
Isada NB, Paar DP, Johnson MP et al (1991) In utero diagnosis of congenital varicella zoster virus infection by chorionic villus sampling and polymerase chain reaction. Am J Obstet Gynecol 165:1727–1730
Kempf W, Meylan P, Gerber S et al (2007) Swiss recommendation for the management of varicella zoster virus infections. Swiss Med Wkly 137:239–251
Kneitz RH, Schubert J, Tollmann F, Zens W, Hedman K, Weissbrich B (2004) A new method for deteremination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis 4:33
Koren G, Money D, Boucher M et al (2002) Serum concentrations, efficacy, and safety of a new, intravenously administerd varicella zoster immune globulin in pregnant women. J Clin Pharmacol 42:267–274
Kustermann A, Zoppini C, Tassis B, Della Morte M, Colucci G, Nicolini U (1996) Prenatal diagnosis of congenital varicella infection. Prenat Diagn 16:71–74
Leineweber N, Grote V, Schaad UB, Heininger U (2004) Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 23:361–363
Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P (2011) Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine 2222–2226
Lindner N, Ferber A, Kopilov U et al (2001) Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther 16:423–426
Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2:371–373
Mouly F, Mirlesse V, Meritet JF et al (1997) Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 177: 894–898
Pasternak B, Hviid A (2010) Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304:859–866
Pretorius DH, Hayward I, Jones KL, Stamm E (1992) Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med 11: 459–463
Robert-Koch-Institut (2003) Zur Seroprävalenz gegen Varicella-Zoster-Virus und zur Verlässlichkeit anamnestischer Angaben. Epidemiol Bull 43:347
Robert Koch-Institut (2005) Neuerungen in den aktuellen Impfempfehlungen der STIKO. Epidemiol Bull 31:273–276
Robert Koch-Institut (2012) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut (Stand: Juli 2012). Epidemiol Bull 30:283–310
Ross DS, Rasmussen SA, Cannon MJ et al (2009) Obstetrician/gynecologists’ knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health 18:1187–1193
Sauerbrei A (2007) Varicella-zoster virus infections during pregnancy. In: Mushahwar K, Congenital and other related infectious diseases of the newborn. Perspectives Med Virol, Amsterdam, Elsevier, 13:51–73
Sauerbrei A (2011) Preventing congenital varicella syndrome with immunization. CMAJ 183:E169–E170
Sauerbrei A, Färber I, Brandstädt A, Schacke M, Wutzler P (2004) Immunofluorescence test for highly sensitive detection of varicella-zoster virus-specific IgG – alternative to fluorescent antibody to membrane antigen test. J Virol Methods 119:25–30
Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R, Wutzler P (2011) Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol 200:99–107
Sauerbrei A, Uebe B, Wutzler P (2003) Molecular diagnosis of zoster post varicella vaccination. J Clin Virol 27:190–199
Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21:545–549
Sauerbrei A, Wutzler P (2003) Das fetale Varizellensyndrom. Monatsschr Kinderheilkd 151:209–213
Sauerbrei A, Wutzler P (2006) Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 44:3094–3097
Sauerbrei A, Wutzler P (2007) Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie. 2. Auflage, Uni-Med, Bremen London Boston
Silverman NS, Ewing SH, Todi N, Montgomery OC (1996) Maternal varicella history as a predictor of varicella immune status. J Perinatol 16:35–38
Ständige Impfkommission am Robert Koch-Institut (2010) Empfehlungen der Ständigen Impfkommission am Robert Koch-Institut / Stand: Juli 2010. Epidemiol Bull 30:279–298
Stone KM, Reiff-Eldridge R, White AD et al (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Res Clin Mol Teratol 70:201–207
Van Der Zwet WC, Vandenbroucke-Grauls CM, vanElburg RM, Cranendonk A, Zaaijer HL (2002) Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 109:79–85
Verstraelen H, Vanzieleghem B, Deroort P, Vanhaesebrouck P, Temmerman M (2003) Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings. Prenat Diagn 23:705–709
Wilson E, Goss MA, Marin M et al (2008) Varicella vaccine exposure during pregnancy: data from 10 years of the pregnancy registry. J Infest Dis 197 (Suppl 2):S178–S184
Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121–124
Yoshida M, Tezuka T, Hiruma M (1995) Detection of varicella-zoster virus DNA in maternal breast milk from a mother with herpes zoster. Clin Diagn Virol 4:61–65
Wutzler P, Knuf M, Liese J (2008) Varizellen: Besserer Schutz durch zweimalige Impfung im Kindesalter. Dtsch Ärztebl 105:567–572
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 DVV, GfV
About this chapter
Cite this chapter
Sauerbrei, A. (2014). Windpocken (Varizellen). In: S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43481-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-43481-9_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43480-2
Online ISBN: 978-3-662-43481-9
eBook Packages: Medicine (German Language)